Alumis Inc. (ALMS)
NASDAQ: ALMS · Real-Time Price · USD
3.590
+0.240 (7.16%)
At close: Jun 6, 2025, 4:00 PM
3.630
+0.040 (1.11%)
After-hours: Jun 6, 2025, 7:57 PM EDT
Alumis Employees
As of December 31, 2024, Alumis had 170 total employees, including 168 full-time and 2 part-time employees. The number of employees increased by 61 or 55.96% compared to the previous year.
Employees
170
Change (1Y)
61
Growth (1Y)
55.96%
Revenue / Employee
$102,288
Profits / Employee
-$2,019,688
Market Cap
195.32M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 170 | 61 | 55.96% |
| Dec 31, 2023 | 109 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
ALMS News
- 9 days ago - Alumis to Present at the Jefferies Global Healthcare Investor Conference - GlobeNewsWire
- 9 days ago - Alumis Completes Enrollment of Pivotal Phase 3 ONWARD Clinical Program of Lead Candidate ESK-001, a Highly Selective, Next-Generation Oral TYK2 Inhibitor for the Treatment of Moderate-to-Severe Plaque Psoriasis - GlobeNewsWire
- 17 days ago - Alumis Completes Merger with ACELYRIN - GlobeNewsWire
- 24 days ago - Alumis Reports First Quarter 2025 Financial Results and Highlights Recent Achievements - GlobeNewsWire
- 25 days ago - Alumis Stockholders Approve Merger with ACELYRIN - GlobeNewsWire
- 6 weeks ago - Alumis and ACELYRIN Announce Amended Merger Agreement - GlobeNewsWire
- 7 weeks ago - ACELYRIN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acelyrin, Inc. - SLRN - Business Wire
- 7 weeks ago - Hyatt Hotels, THOR Industries And Other Big Stocks Moving Lower On Monday - Benzinga